You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

Current Opinion in Rheumatology

Mission Statement

Current Opinion in Rheumatology is one of 23 Current Opinion journals that aims to help clinicians and researchers keep up-to-date in a systematic way with the vast amount of information published in rheumatology. Current Opinion in Rheumatology guides you through the literature with: Review articles by the world's experts in rheumatology-written in clear, concise, and accessible language, expert commentary and opinion about the most interesting and relevant papers published in rheumatology, comprehensive references and bibliographies, providing a ready resource and search-enabled full-text web site.

Contact Information

Lippincott Williams & Wilkins
530 Walnut Street
Philadelphia, PA 19106
215-531-8300
fax: 215-531-8902

Publisher: Diana Pesek
[email protected]
215-521-8348

Subscription and Reprint Information

Subscriptions:
LWW
16522 Hunters Green Parkway
Hagerstown, MD 21740
800-638-3030

Reprints: Dave Hughmanick
[email protected]
410-528-4077

Advertising: Linda Martin
[email protected]
212-886-1278

Copyright

© Lippincott Williams & Wilkins. No portion(s) of the work(s) may be reproduced without written consent from the Publisher.

Disclaimer

The contents of this site include information relating to general principals of medical care that should not be construed as specific instructions for individual patients. Application of this information in a particular situation remains the professional responsibility of the practitioner. Lippincott Williams & Wilkins assumes no liability or responsibility for any errors or omissions in such information. Some drugs and medical devices presented in this publication have Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the health care provider to ascertain the FDA status of each drug or device planned for use in their clinical practice. Any information posted to discussion forums (moderated and un moderated) is for informational purposes only. We are not responsible for the information or the result of its practice.

Editorial Information

Editor: Cornelia M Weyand, MD
c/o Current Opinion in Rheumatology
Lippincott Williams & Wilkins
530 Walnut Street
Philadelphia, PA 19106
215 521 8488-Fax